Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1989 Jul;80(7):662–669. doi: 10.1111/j.1349-7006.1989.tb01694.x

Killing of Alveolar Macrophages and of Monocytes that Have Responded to Granulocyte‐Macrophage Colony‐stimulating Factor by Human Lymphokine‐activated Killer Cells

Saburo Sone 1,✉, Noriaki Inamura 1, Sukh Mahendra Singh 1, Akio Okubo 1, Hiroaki Yanagawa 1, Mie Nakanishi 1, Takeshi Ogura 1
PMCID: PMC5917807  PMID: 2507489

Abstract

The susceptibilities of human blood monocytes and alveolar macrophages (AM) to cytotoxicity mediated by lymphokine (IL‐l)‐activated killer (LAK) cells were examined. Monocytes and AM of healthy donors were obtained by counter‐flow centrifugal elutriation (CCE) and bronclioalvcolar lavage, respectively. The LAK activity induced by incubation of blood mononuclear cells (MNC) for 4 days with recombinant interleukin 2 (IL‐2) was measured by a 4‐h 51Cr release assay. The LAK cells were not cytotoxic to freshly isolated monocytes, but were cytotoxic to autologous fresh AM and monocytes that had been incubated for more than 4 days in medium alone. Blood monocytes that had been incubated for 4‐ days in medium with granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), macrophage colony‐stimulating factor (M‐CSF) or interleukin 3 (IL‐3) were much more susceptible than untreated monocytes to the cytotoxicity of LAK cells. When blood monocytes were separated by CCE into subpopulations of three sizes (small, medium and large), the medium‐ and large‐sized monocytes showed greater responses to GM‐CSF in terms of DNA synthesis and colony formation than the small‐sized cells. After treatment with GM‐CSF for 4 days, these medium and large monocytes were more susceptible than the small monocytes to the cytotoxic action of LAK cells. These results suggest that LAK cells may be important in situ in down‐regulating the functions of mature macrophages and blood monocytes that have responded to GM‐CSF.

Keywords: Macrophages, Interleukin 2, Colony‐stimulating factor, Lymphokine‐activated killer cell

Full Text

The Full Text of this article is available as a PDF (520.8 KB).

REFERENCES

  • 1. ) Unanue , E. R.The regulatory role of macrophages in antigenic stimulation. Part two. Symbiotic relationship between lymphocytes and macrophages . Adv. Immunol , 31 , 1 – 15 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Fidler , I. J.Macrophages and metastasis: a biological approach to cancer therapy. Presidential address . Cancer Res. , 45 , 4714 – 4728 ( 1985. ). [PubMed] [Google Scholar]
  • 3. ) Sone , S.Role of alveolar macrophages in pulmonary neoplasias . Biochim. Biophys. Acta , 823 , 227 – 245 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Metcalf , D.The molecular biology and functions of the granulocyte‐macrophage colony‐stimulating factors . Shod , 67 , 257 – 267 ( 1986. ). [PubMed] [Google Scholar]
  • 5. ) Sieff , C. A.Hematopoietic growth factors . J. Clin. Invest. , 79 , 1549 – 1557 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Chen , B. D‐M. , Clark , C. R. and Chou , T.Granulocyte/ macrophage colony‐stimulating factor stimulates mono‐cyte and tissue macrophage proliferation and enhances their responsiveness to macrophage colony‐stimulating factor . Blood. 71 , 997 – 1002 ( 1988. ). [PubMed] [Google Scholar]
  • 7. ) Reed , S. G. , Nathan , C. F. , Phil , D. A. , Rodricks , P. , Shanebeck , K. , Conlon , P. J. and Grabstein , K. H.Recombinant granulocyte/macrophage colony stimulating factor activates the macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma . J. Exp. Med. , 166 , 1734 – 1746 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Coleman , D. L. , Chodakewitz , J. A. , Bartiss , A. H. and Mellors , J. W.Granulocyte‐macrophage colony‐stimulating factor enhances selective effector functions of tissue derived macrophages . Blood , 72 , 573 – 578 ( 1988. ). [PubMed] [Google Scholar]
  • 9. ) Falk , L. A , Wahl , L. M. and Vogel , S. N.Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured with granulocyte‐macrophage colony stimulating factor . J. Immunol. , 140 , 2652 – 2660 ( 1988. ). [PubMed] [Google Scholar]
  • 10. ) Grabstein , K. H. , Urdal , D. L. , Tushinski , R. J. , Mochizuki , D. Y. , Prince , V. L. , Cantrell , M. A. , Gillis , S. and Conlon , P. J.Induction of macrophage turaoricidal activity by granulocyte‐macrophage colony‐stimulating factor . Science , 232 , 506 – 508 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Kurland , J. L , Pelus , L. M. , Ralph , R. , Bockman , R. S. and Moore , M. A.Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role of colony‐stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation . Proc. Natl. Acad. Sci. USA , 76 , 2326 – 2330 ( 1979. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Cannistra , S. A. , Vallenga , E. , Groshek , P. , Rambaldi , A. and Griffin , J. D.Human granulocyte‐monocyte colony stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor‐dependent mechanism . Blood , 71 , 672 – 676 ( 1988. ). [PubMed] [Google Scholar]
  • 13. ) Warren , M. K. and Ralph , P.Macrophage growth factor CSF‐1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity . J. Immunol. , 137 , 2281 – 2285 ( 1986. ). [PubMed] [Google Scholar]
  • 14. ) Grimm , E. A. , Mazumder , A. , Zhang , H. Z. and Rosenberg , S. A.Lymphokine‐activated killer cell phenomenon. Lysis of natural killer‐resistant fresh solid tumor cells by interleukin‐2 activated autologous human peripheral blood lymphocytes . J. Exp. Med. , 155 , 1823 – 1841 ( 1982. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. ) Lotze , M. T. , Grimm , E. A. , Mazumder , A. , Strausser , J. L. and Rosenberg , S. A.Lysis of fresh and cultured autologous tumor by lymphocytes cultured in T‐cell growth factor . Cancer Res. , 41 , 4420 – 4425 ( 1981. ). [PubMed] [Google Scholar]
  • 16. ) Hersey , S. , Bindon , D. , Edwards , A. , Murray , E. , Phillips , G. and McCarthy , W. H.Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by cultures with interleukin‐2 . Int. J. Cancer , 28 , 695 – 703 ( 1981. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Itoh , K. , Tilden , A. B. and Balch , C. M.Role of inter‐leukin 2 and a serum suppressive factor on the induction of activated killer cell cytotoxic for autologous human melanoma cells . Cancer Res. , 45 , 3173 – 3178 ( 1985. ). [PubMed] [Google Scholar]
  • 18. ) Sone , S. , Utsugi , T. , Nii , A. and Ogura , T.Effects of human alveolar macrophages on the induction of lymphokine (IL‐2)‐activated killer cells . J. Immunol. , 139 , 29 – 34 ( 1987. ). [PubMed] [Google Scholar]
  • 19. ) Nii , A. , Sone , S. , Utsugi , T. and Ogura , T.Up‐ and down‐regulation of human lymphokine (IL‐2)‐activated killer cell induction by monocytes depending on their functiona) state . Int. J. Cancer , 41 , 33 – 40 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Sone , S. , Inamura , N. , Nii , A. and Ogura , T.Heterogeneity of human lymphokine (IL‐2)‐activated killer cell precursors and regulation of their LAK induction by blood monocytes . Int. J. Cancer , 42 , 428 – 434 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 21. ) Fujimori , Y. , Kara , H. and Nagai , K.Effect of lym‐phokine‐activated killer cell fraction on the development of human hematopoietic progenitor cells . Cancer Res. , 48 , 534 – 538 ( 1987. ). [PubMed] [Google Scholar]
  • 22. ) Nagler , A. , Greenberg , P. L. , Lanier , L. L. and Phillips , J. H.The effects of recombinant interleukin 2‐activated natural killer cells on autologous peripheral blood hematopoietic progenitors . J. Exp. Med. , 168 , 47 – 54 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Djeu , J. Y. and Blanchard , D. K.Lysis of human monocytes by lymphokine‐activated killer cells . Cell. Immunol. , 111 , 55 – 65 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Djeu , J. Y. and Blanchard , D. K.Interferon‐gamma‐induced alterations of monocyte susceptibility to lysis by autologous lymphokine‐activated killer (LAK) cells . Int. J. Cancer , 42 , 449 – 54 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Sone , S. , Mutsuura , S. , Ogawara , M. and Tsubura , E.Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in Hposomes on tumor cell killing by human monocytes . J. Immunol. , 132 , 2105 – 2110 ( 1984. ). [PubMed] [Google Scholar]
  • 26. ) Nishida , T. , Nishino , N. , Takano , M. , Kawai , K. , Bando , K. , Masui , Y. , Nakai , S. and Hirai , Y.cDNA cloning of IL‐lα and IL‐1ß from mRNA of U937 cell line . Biochem. Biophys. Res. Commun. , 143 , 345 – 352 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Sone , S. and Tsubura , E.Human alveolar macrophages: potentiation of their tumoricidal activity by Hposome‐encapsulated muramyl dipeptide . J. Immunol , 129 , 1313 – 1317 ( 1982. ). [PubMed] [Google Scholar]
  • 28. ) Wakasugi , H. , Bertoglio , J. , Tursz , T. and Fradelizi , D.IL‐2 receptor induction on human T lymphocytes: role for IL‐2 and monocytes . J. Immunol. , 135 , 321 – 327 ( 1985. ). [PubMed] [Google Scholar]
  • 29. ) Shirakawa , F. , Tanaka , Y. , Eto , S. , Suzuki , H. , Yodoi , J. and Yamashita , Y.Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer‐like cells (YT cells) . J. Immunol , 137 , 551 – 556 ( 1986. ). [PubMed] [Google Scholar]
  • 30. ) Haskill , S. , Johnson , C. , Eierman , D. , Becker , S. and Warren , K.Adherence induces selective mRNA expression of monocyte mediators and proto‐oncogenes . J. Immunol , 140 , 1690 – 1694 ( 1988. ). [PubMed] [Google Scholar]
  • 31. ) Sone , S. , Moriguchi , S. , Shimizu , E. , Ogushi , F. and Tsubura , E.In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin . Cancer Res. , 42 , 2227 – 2231 ( 1982. ). [PubMed] [Google Scholar]
  • 32. ) Utsugi , T. and Sone , S.Comparative analysis of the priming effects of human interferon‐γ, α and ß on syner‐gism with muramyl dipeptide analog for anti‐tumor expression of human blood monocytes . J. Immunol. , 136 , 1117 – 1122 ( 1986. ). [PubMed] [Google Scholar]
  • 33. ) Kleinerman , E. S. and Herberman , R. B.Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells . J. Immunol. , 133 , 4 – 8 ( 1984. ). [PubMed] [Google Scholar]
  • 34. ) Onozaki , K. , Matsushima , K. , Kleinerman , E. S. , Saito , T. and Oppenheim , J. J.Role of interleukin 1 in promoting human monocyte‐mediated tumor cytotoxicity . J. Immunol , 135 , 314 – 320 ( 1985. ). [PubMed] [Google Scholar]
  • 35. ) Mace , K. F. , Ehrke , M. J. , Hori , K , Maccubbin , D. L. and Mihich , E.Role of tumor necrosis factor in macrophage activation and tumoricidal activity . Cancer Res. , 48 , 5427 – 5432 ( 1988. ). [PubMed] [Google Scholar]
  • 36. ) Esa , A. H. , Donnenberg , A. D. and Hess , A. D.Immunological heterogeneity of human monocyte subsets prepared by counterflow centrifugal elutriation . Immunology , 59 , 95 – 99 ( 1986. ). [PMC free article] [PubMed] [Google Scholar]
  • 37. ) MaCarley , D. L. , Shah , V. O. and Weiner , R. S.Purified human monocyte subsets as effector cells in antibody dependent cellular cytotoxicity (ADCC) . J. Immunol , 131 , 1780 – 1783 ( 1983. ). [PubMed] [Google Scholar]
  • 38. ) Khansari , N. , Chou , Y. and Fudenberg , H.Human monocyte heterogeneity: interleukin‐1 and prostaglandin E2 production by separate subsets . Eur. J. Immunol , 15 , 48 – 51 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 39. ) Rosenberg , S. A. , Lotze , M. T. , Muul , L. M. , Chang , A. E. , Avis , F. P. , Leitman , S. , Linehan , W. M. , Robertson , C. N. , Lee , R. E. , Rubin , J. T. , Seipp , C. A. , Simpson , C. G. and White , D. E. A.progress report of the treatment of 157 patients with advanced cancer using lymphokine‐activated killer cells and interleukin‐2 or high‐dose of interleukin 2 alone . N. Engl. J. Med. , 316 , 889 – 897 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 40. ) West , W. H , Tauer , K. W. , Yannelli , J. R , Marshall , G. D. , Orr , D. W. , Thurman , G. B. and Oldham , R. K.Constant infusion of recombinant interleukin‐2 in adoptive immunotherapy of advanced cancer. JV . Engl. J. Med. , 316 , 898 – 905 ( 1987. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES